Work

Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis

Year: 2022

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Critical Reviews in Oncology/Hematology

DOI: 10.1016/j.critrevonc.2022.103801

Authors: Giuseppe Fallara, Federico Belladelli, Daniele Robesti, Daniele Raggi, Luigi Nocera, Laura Marandino, Matthew D. Galsky, Francesco Montorsi, Bernard Malavaud, Guillaume Ploussard, Andrea Necchi, Alberto Martini

Institutions: IRCCS Ospedale San Raffaele, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Institut universitaire du cancer de Toulouse Oncopole

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Merck, Ipsen

OpenAlex ID: W4293564028

FWCI: 0.578

Cites: 46

Cited by: 10

Related to: 10